Published

96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Biological Psychiatry
Date: 2023-04-09
Source: OpenAlex
DOI: 10.1016/j.biopsych.2023.02.336
PubMed: Unavailable

Authors

Scott Aaronson Tammy Miller Samuel Rudow MacKenzie Forbes Audrey Shoultz Trisha Suppes

Watch author

Topics and keywords

psilocybin Depression Other Psilocybin Depression (economics)Bipolar disorder Mood Psychiatry Medicine Psychology Hallucinogen Economics Macroeconomics Psychedelics and Drug Studies Chemical synthesis and alkaloids

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression2023-04-09

Related papers

Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisThe International Journal of Psychiatry in Medicine · 2025-04-24 194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08 187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08 186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25 Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit postsJournal of Affective Disorders · 2026-01-19 Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trialGeneral Hospital Psychiatry · 2025-08-11 Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05